BSECompany Update8 Oct 2026 · 8 Oct 2026, 11:16 am
Certificate under Regulation 74(5) of the SEBI(Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI Summary
Venmax Drugs and Pharmaceuticals Ltd has submitted a certificate under Regulation 74(5) of the SEBI(Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018